Citius Pharmaceuticals, Inc. - COM NEW (CTXR)

Historical Portfolio Holders from Q3 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q1 2024
26.7 M
Holdings value Q1 2024
$24 M
Value change Q1 2024
+$209 K
Grand Portfolio weight change Q1 2024
+0%
Number of holders
69
Number of buys Q1 2024
25
Number of sells Q1 2024
-29
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
17322U207
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 26.7 M $24 M +$209 K $0.90 69
2023 Q4 26.5 M $20.1 M +$1.44 M $0.76 70
2023 Q3 24.9 M $17 M -$571 K $0.68 71
2023 Q2 25.3 M $30.3 M +$13 M $1.20 71
2023 Q1 14.5 M $16.9 M +$346 K $1.17 53
2022 Q4 14.1 M $11.2 M +$248 K $0.79 46
2022 Q3 11 M $13.3 M -$1.43 M $1.21 44
2022 Q2 15.1 M $13.9 M -$9.98 M $0.92 48
2022 Q1 24.1 M $43.1 M -$570 K $1.79 64
2021 Q4 16.2 M $24.9 M -$2.18 M $1.54 66
2021 Q3 25.1 M $50.9 M -$903 K $2.03 66
2021 Q2 25.1 M $87.4 M +$51 M $3.48 68
2021 Q1 10.8 M $19.3 M +$16.4 M $1.78 37
2020 Q4 1.81 M $1.85 M +$728 K $1.02 22
2020 Q3 1.05 M $1.09 M +$248 K $1.04 15
2020 Q2 969 K $1.09 M -$545 K $1.12 13
2020 Q1 2.14 M $1.3 M +$856 K $0.59 9
2019 Q4 684 K $698 K -$2.45 M $1.02 8
2019 Q3 2.69 M $2.85 M +$2.43 M $0.95 6
2019 Q2 624 K $612 K +$245 K $1.00 9
2019 Q1 351 K $498 K -$521 K $1.42 10
2018 Q4 926 K $961 K +$670 K $1.03 7
2018 Q3 253 K $434 K -$478 K $1.71 9
2018 Q2 525 K $1.21 M -$400 K $2.30 6
2018 Q1 699 K $2.17 M +$1.44 M $3.09 5
2017 Q4 237 K $925 K +$844 K $3.90 6
2017 Q3 23.7 K $75 K +$75 K $3.18 3